ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
150 hedge funds and large institutions have $566M invested in Intercept Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 41 increasing their positions, 55 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
25% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 55
59% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 39
Holders
150
Holding in Top 10
1
Calls
$24.8M
Puts
$31.9M
Top Buyers
| 1 | +$14.1M | |
| 2 | +$11.8M | |
| 3 | +$10.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.57M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$5.47M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$14.5M | |
| 3 | -$11.7M | |
| 4 |
Renaissance Technologies
New York
|
-$9.27M |
| 5 |
JPMorgan Chase & Co
New York
|
-$8.14M |